Cilexa safely curbs depression in the young

	Tweet

Treatment with the antidepressant Cilexa significantly reduces symptoms of major depression in children and adolescents, researchers report.

Dr. Karen Dineen Wagner of the University of Texas Medical Branch, Galveston, and colleagues note in the American Journal of Psychiatry that previous open-label trials have indicated that Cilexa (also known technically as citalopram) was safe and effective in young patients.

To investigate further, the researchers conducted an 8-week long double-blind study of 174 patients, ranging in age from 12 to 17, with major depressive disorder.

They were randomly assigned to treatment with citalopram or an inactive placebo. Patients in the citalopram group showed a significantly greater reduction in average scores on the Children’s Depression Rating Scale than did those in the placebo group.

--------------------------------------------------------
Welcome to our Online Pharmacy

The online prescription medication store you can trust. » »
---------------------------------------------------------

Differences between the citalopram and placebo groups were seen after one week, and continued until the end of the study. At that point, the 36 percent response rate among participants given citalopram was significantly greater than the 24 percent seen in those given a placebo.

The rate of adverse events was similar between the groups, and none was serious, Wagner’s team found.

These findings, the researchers conclude, “Further support the use of citalopram in children and adolescents suffering from depression.”

SOURCE: American Journal of Psychiatry, June 2004.

RELATED STORIES:
Some Ethnic Groups More Susceptible to Adverse Drug Reactions   Abuse of some illegal drugs on rise globally   FDA cracks down on 5 makers of e-cigarettes   US warns about risks of Boehringer AIDS drug   Police arrest “Viagra gang” suspect   US group questions artificial sweetener Splenda   Vioxx study finds arthritis drug increases heart attack risk   California drug offenders lapse despite rehab   Survey finds 80 pct of U.S. doctors witness mistakes   Novartis Warns of Skin Problems with Epilepsy Drug   Shortfall in malaria drug causing deaths--MSF   Abbott AIDS drug price claims were misleading

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]